HPLC purity
Reverse-phase HPLC with UV detection; ≥99% area purity target.
Growth-hormone axis · worldwide
Lyophilized ipamorelin for qualified B2B research buyers, and private-label brand owners. ≥99% HPLC purity target, batch-linked COA, HPLC chromatogram and MS identity record. Often requested alongside CJC-1295 for laboratory research. Reply ≤4h.
Vial illustrations reflect supplied lyophilized format. Lot codes are sample identifiers; production lots carry their own batch references.
| Compound | Ipamorelin |
|---|---|
| Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Molecular weight | ≈ 711.85 g/mol |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 5 mg (custom on request) |
| Documentation | Batch-linked COA + HPLC chromatogram + MS identity record for every production lot |
| Storage | 2–8 °C protected from light; long-term −20 °C |
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | From 50 vials | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Documentation
COA, HPLC chromatogram, MS identity confirmation, water content and storage notes. Buyer track and destination confirmed before invoicing.
Reverse-phase HPLC with UV detection; ≥99% area purity target.
Mass spectrometry identity confirmation against ipamorelin reference profile.
Lot code printed on vial label and reflected in the document pack.
FAQ
Ipamorelin is a selective growth hormone secretagogue (pentapeptide) studied for GH release with minimal cortisol or prolactin elevation. It is sourced by qualified B2B buyers, research organizations and qualified B2B research buyers for protocol formulation.
Research organizations frequently pair ipamorelin (a GHRP) with CJC-1295 (a GHRH analog, with or without DAC) for combined coverage of growth-hormone axis pathways. We supply both as separate lyophilized vials.
Sample lots from 50 vials; production lots from 200 vials with tier pricing.
Yes — qualified B2B research buyers receive context-specific documentation. We do not supply regulated bulk-substance facilities for compounds covered by FDA bulks restrictions.
Yes. Neutral or branded labels, carton design, document packs and lot-code handling are part of the OEM service path.
Related compounds